menu
    • menu
    [{"orgOrder":0,"company":"Northumbria University","sponsor":"Finzelberg GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"UNITED KINGDOM","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Verbena Officinalis L.","moa":"Undisclosed","graph1":"Neurology","graph2":"Undisclosed","graph3":"Northumbria University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Northumbria University \/ Finzelberg GmbH","highestDevelopmentStatusID":"1","companyTruncated":"Northumbria University \/ Finzelberg GmbH"},{"orgOrder":0,"company":"Jos\u00e9 Enrique de la Rubia Ort\u00ed, Ph","sponsor":"Vinabas Formulations SL","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"","productType":"Plant Extract\/Herbal","year":"2025","type":"Inapplicable","leadProduct":"Verbena Officinalis L.","moa":"Undisclosed","graph1":"Psychiatry\/Psychology","graph2":"Undisclosed","graph3":"Jos\u00e9 Enrique de la Rubia Ort\u00ed, Ph","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Jos\u00e9 Enrique de la Rubia Ort\u00ed, Ph \/ Vinabas Formulations SL","highestDevelopmentStatusID":"1","companyTruncated":"Jos\u00e9 Enrique de la Rubia Ort\u00ed, Ph \/ Vinabas Formulations SL"}]

    Find Clinical Drug Pipeline Developments & Deals for Verbena Officinalis L.

    Menu

    Verbena Officinalis L.

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            José Enrique de la Rubia Ortí, Ph

                            Country arrow
                            PackExpo
                            Not Confirmed

                            José Enrique de la Rubia Ortí, Ph

                            Country arrow
                            PackExpo
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Verbena Officinalis L.

                            Therapeutic Area : Psychiatry/Psychology

                            Study Phase : Undisclosed

                            Sponsor : Vinabas Formulations SL

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy of Satisens® in Reducing Emotional Eating

                            Details : Lemon Verbena is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Binge-Eating Disorder.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            July 22, 2025

                            Lead Product(s) : Verbena Officinalis L.

                            Therapeutic Area : Psychiatry/Psychology

                            Highest Development Status : Undisclosed

                            Sponsor : Vinabas Formulations SL

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Northumbria University

                            Country arrow
                            PackExpo
                            Not Confirmed

                            Northumbria University

                            Country arrow
                            PackExpo
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Verbena Officinalis L.

                            Therapeutic Area : Neurology

                            Study Phase : Undisclosed

                            Sponsor : Finzelberg GmbH

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of Lemon Verbena Extract Supplementation in Sub-ADHD Children

                            Details : Lemon Verbena is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognition Disorders.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            July 27, 2022

                            Lead Product(s) : Verbena Officinalis L.

                            Therapeutic Area : Neurology

                            Highest Development Status : Undisclosed

                            Sponsor : Finzelberg GmbH

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth